| dc.contributor.author | Hussain, SA | |
| dc.contributor.author | Ansari, J | |
| dc.contributor.author | Huddart, R | |
| dc.contributor.author | Powers, DG | |
| dc.contributor.author | Lyons, J | |
| dc.contributor.author | Wylie, J | |
| dc.contributor.author | Vilarino-Varlela, M | |
| dc.contributor.author | Elander, NO | |
| dc.contributor.author | McMenemin, R | |
| dc.contributor.author | Pickering, LM | |
| dc.contributor.author | Faust, G | |
| dc.contributor.author | Chauhan, S | |
| dc.contributor.author | Jackson, RJ | |
| dc.date.accessioned | 2017-05-23T15:48:19Z | |
| dc.date.issued | 2017-03-01 | |
| dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000396186400003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
| dc.identifier.citation | INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (3), pp. 768 - 772 | |
| dc.identifier.issn | 1019-6439 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/654 | |
| dc.identifier.eissn | 1791-2423 | |
| dc.identifier.doi | 10.3892/ijo.2017.3847 | |
| dc.format.extent | 768 - 772 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| dc.subject | vinflunine | |
| dc.subject | TCCU | |
| dc.subject | second line | |
| dc.subject | overall survival | |
| dc.title | VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2016-11-14 | |
| rioxxterms.versionofrecord | 10.3892/ijo.2017.3847 | |
| rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
| rioxxterms.licenseref.startdate | 2017-03 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | INTERNATIONAL JOURNAL OF ONCOLOGY | |
| pubs.issue | 3 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart) | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart) | |
| pubs.publication-status | Published | |
| pubs.volume | 50 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Clinical Academic Radiotherapy (Huddart) | |
| dc.contributor.icrauthor | Huddart, Robert | |
